Skip to content

Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary Disease

Changes in Leukotrienes During Cardiac Surgery in Patients With Chronic Obstructive Pulmonary Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00734266
Enrollment
20
Registered
2008-08-14
Start date
2007-04-30
Completion date
2010-12-31
Last updated
2013-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammatory Response During Cardiac Surgery, Lung Dysfunction

Keywords

COPD, CPB, Leukotrienes

Brief summary

The hypotheses of this study are that: * Production and release of inflammatory substances called leukotrienes are increased during heart surgery with use of a heart-lung machine in humans; * The increase in these leukotrienes levels after heart surgery is higher in patients with bronchitis and/or emphysema than in patients without previous history of lung disease; * Levels of leukotrienes are directly correlated with worsening of lung function during and after heart surgery.

Detailed description

In this project, we will test the hypothesis that cys-leukotrienes are released and correlated with the impairment of the lung function after cardiac surgery in patients with COPD. If such hypothesis is substantiated in the study, it would allow us to propose the use of leukotriene inhibitors in the peri-operative period to improve pulmonary function and to decrease complications after cardiac surgery in COPD patients.

Interventions

None listed

Sponsors

Merck Sharp & Dohme LLC
CollaboratorINDUSTRY
Massachusetts General Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult patients schedules to undergo cardiac surgery with use of CPB.

Exclusion criteria

* inability to provide consent; * previous diagnosis of asthma; * acute pre-operative respiratory failure; * emergency surgery.

Design outcomes

Primary

MeasureTime frame
urine cysteinyl leukotrieneintra-operative

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026